Home>CELL THERAPY>Holoderm


[Prescription drug] [National Health Insurance reimbursement]


Kaloderm® is the world's third allogeneic cell therapy product for healing wounds. 


It is cultured from the master and working cell banks that contain the keratinocytes from the foreskin of a circumcised infant. We have the technology to propagate the cells almost indefinitely, meaning that Kaloderm® will always be made from the single source and maintain the same quality. 

Kaloderm® is mass-produced on a regular basis and can be stored frozen at -60℃ for 24 months. Since the 2005 KFDA approval, 300,000 sheets have been used, mostly in burn clinics.


DFU indication was added in 2010 and approved for National Health Insurance reimbursement in 2019.


1. Promote re-epithelialization of deep 2nd degree burn

2. Promote the healing of non-infected

   diabetic foot ulcer wounds

Active Ingredient

Allogeneic Keratinocytes